Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 2
1992 4
1993 6
1994 15
1995 14
1996 15
1997 11
1998 14
1999 12
2000 20
2001 9
2002 24
2003 21
2004 18
2005 23
2006 20
2007 7
2008 18
2009 17
2010 27
2011 25
2012 19
2013 21
2014 24
2015 31
2016 14
2017 8
2018 8
2019 7
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

424 results
Results by year
Filters applied: . Clear all
Page 1
Effects of oral conjugated equine estrogens with or without medroxyprogesterone acetate on incident hypertension in the Women's Health Initiative hormone therapy trials.
Swica Y, Warren MP, Manson JE, Aragaki AK, Bassuk SS, Shimbo D, Kaunitz A, Rossouw J, Stefanick ML, Womack CR. Swica Y, et al. Menopause. 2018 Jul;25(7):753-761. doi: 10.1097/GME.0000000000001067. Menopause. 2018. PMID: 29381666 Free PMC article. Clinical Trial.
Progestogen safety and tolerance in hormonal replacement therapy.
Palacios S, Mejía A. Palacios S, et al. Expert Opin Drug Saf. 2016 Nov;15(11):1515-1525. doi: 10.1080/14740338.2016.1223041. Epub 2016 Aug 22. Expert Opin Drug Saf. 2016. PMID: 27548404 Review.
Effects of tibolone and continuous combined conjugated equine estrogen/medroxyprogesterone acetate on the endometrium and vaginal bleeding: results of the OPAL study.
Langer RD, Landgren BM, Rymer J, Helmond FA; OPAL Investigators. Langer RD, et al. Am J Obstet Gynecol. 2006 Nov;195(5):1320-7. doi: 10.1016/j.ajog.2006.03.045. Epub 2006 Jul 26. Am J Obstet Gynecol. 2006. PMID: 16875644 Clinical Trial.
424 results
Jump to page
Feedback